BRCA1 and BRCA2 genetic testing in breast and/or ovarian cancer families in Iran

Yakhteh

Volumn 12, Issue 3, 2010, Pages 329-340

  Keshavarzi, Fatemeh ^a   Javadi, Gholam Reza ^a   Nafissi, Nahid ^b   Akbari, Mohammad Esmail ^b   Yassaee, Vahid Reza ^b   Farzad, Maryam Sharafi ^c   Zeinali, Sirous ^c,d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Kawsar Human Genetics Research Center   (Iran)

^d PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

BRCA1; BRCA2; Breast cancer; Dna sequencing; Familial cancer

Indexed keywords

ASPARAGINE; BRCA1 PROTEIN; BRCA2 PROTEIN; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; LEUCINE; PROLINE; SERINE; VALINE;

ARTICLE; BRCA 1 GENE; BRCA 2 GENE; BREAST CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; FAMILY HEALTH; GENE; GENE LOCUS; GENETIC SCREENING; GENOTYPE; GERM LINE; HIGH RISK POPULATION; HUMAN; IRAN; MISSENSE MUTATION; MUTATIONAL ANALYSIS; OVARY CANCER; SPLICING DEFECT;

EID: 78650431913     PISSN: 15614921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ripperger T, Gadzicki D, Meindi A, Schlegelberger D. Breast cancer susceptibility: Current knowledge and implications for genetic counseling. Eur J Hum Genet. 2009;17:722-731.
2. Falagas ME, Zarkadoulia EA, loannidou EN, Peppas G, Christodoulou C, Rafailidis Pl. The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res. 2007; 9: R44.
3. Nathanson K.N. Wooster R. Weber B.L. Breast cancer genetics: What we know and what we need Nature Medicine 2001 7 5 552-556 DOI 10.1038/87876 3. Nathanson KL, Wooster R, Weber BL. Breast cancer genetics: What we know and what we need. Nat Med.. 2001;7:552-556. (Pubitemid 32448321)
4. Fackenthal J.D. Olopade O.I. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations Nature Reviews Cancer 2007 7 12 937-948 DOI 10.1038/nrc2054, PII NRC2054 4. Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007; 7: 937-948. (Pubitemid 350165853)
5. King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003; 302: 643-646.
6. Le Page F, Randrianarison V, Marot D, Cabannes J, Perricaudet M, Feunteun J, et al. BRCA1 and BRCA2 Are Necessary for the Transcription-Coupled Repair of the Oxidative 8-Oxoguanine Lesion in Human Cells. Cancer Res. 2000; 60: 5548-5552.
7. Starita LM, Parvin JD. The multiple nuclear functions of BRCA1 : transcription, ubiquitination and DNA repair. Curr Opin Cell Biol. 2003; 15: 345-350.
8. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer. 2004; 4: 665-676.
9. Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, et al. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet. 2000; 67: 841-850.
10. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003; 72: 1117-1130.
11. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2 and TP53 in families at high risk of breast cancer. JAMA. 2006; 295: 1379-1388.
12. Campos B, Diez O, Domènech M, Baena M, Balmaña J, Sanz J, et al. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain. Hum Mutat. 2003; 22: 337.
13. Beggs AD, Hodgson SV. Genomics and breast cancer: The different levels of inherited susceptibility Eur J Hum Genet. 2009; 17: 855-856.
14. Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, et al. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France. Genes, Chromosomes Cancer. 2005; 43: 404-413.
15. Tommasi S, Crapolicchio A, Lacalamita R, Bruno M, Monaco A, Petroni S , et al. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutat Res. 2005; 578: 395-405.
16. Deng CX, Wang RH. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Genet. 2003; 12 Spec No 1: R113-123.
17. Arun B, Vogel KJ, Lopez A, Hernandez M, Atchley D, Broglio KR, et al. igh prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers. Cancer Prev Res; 2009; 2(2): 122-127.
18. Scully R. Puget N. BRCA1 and BRCA2 in hereditary breast cancer Biochimie 2002 84 1 95-102 DOI 10.1016/S0300-9084(01)01359-1, PII S0300908401013591 18. Scully R, Puget N. BRCA1 and BRCA2 in hereditary breast cancer. Biochimie. 2002; 84: 95-102. (Pubitemid 34477097)
19. Chen L, Nievera CJ, Lee AY, Wu X. Cell cycle-dependent complex formation of BRCA1. CtlP. MRN is important for DNA double-strand break repair. J Biol Chem. 2008;283:7713-7720.
20. Vallon-Christersson J. Cayanan C. Haraldsson K. Loman N. Bergthorsson J.T. Broondum-Nielsen K. Gerdes A.-M. Mooller P. Kristoffersson U. Olsson H. Borg A. Monteiro A.N.A. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families Human Molecular Genetics 2001 10 4 353-360 20. Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, Brondum-Nielsen K, et al. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet. 2001; 10: 353-360. (Pubitemid 32166546)
21. Hayes F, Cayanan C, Barilla D, Monteiro AN. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.Cancer Res. 2000; 60: 2411-2418.
22. Couch F.J. DeShano M.L. Blackwood M.A. Calzone K. Stopfer J. Campeau L. Ganguly A. Rebbeck T. Weber B.L. Jablon L. Cobleigh M.A. Hoskins K. Garber J.E. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer New England Journal of Medicine 1997 336 20 1409-1415 DOI 10.1056/NEJM199705153362002 22. Couch FJ, DeShano ML, Blackwood MA Calzone K, Stopfer J, Campeau L. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997; 336: 1409-1415. (Pubitemid 27208599)
23. Frank T.S. Deffenbaugh A.M. Reid J.E. Hulick M. Ward B.E. Lingenfelter B. Gumpper K.L. Scholl T. Tavtigian S.V. Pruss D.R. Critchfield G.C. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals Journal of Clinical Oncology 2002 20 6 1480-1490 DOI 10.1200/JCO.20.6.1480 23. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. Clinical characteristics of individuals with germ line mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002; 20: 1480-1490. (Pubitemid 34260526)
24. Evans DG, Lalloo F, Wallace A, Rahman N. Update on the Manchester Scoring System for BRCA1 and BRCA2 testing. J Med Genet. 2005; 42(7): e39.
25. Antoniou A.C. Pharoah P.P.D. Smith P. Easton D.F. The BOADICEA model of genetic susceptibility to breast and ovarian cancer British Journal of Cancer 2004 91 8 1580-1590 25. Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. BrJ Cancer. 2004; 91:1580-1590. (Pubitemid 39486366)
26. Lin YP, Chen YL, Chang HT, Li S. Nature of genetic variants in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Life Science Journal. 2009; 6:99-103.
27. Abkevich V. Zharkikh A. Deffenbaugh A.M. Frank D. Chen Y. Shattuck D. Skolnick M.H. Gutin A. Tavtigian S.V. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation Journal of Medical Genetics 2004 41 7 492-507 27. Abkevich V, Zharkikh A, Deffenbaugh AM, Frank D, Chen Y, Shattuck D, et al. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet. 2004; 41:492-507. (Pubitemid 38932109)
28. De Silva W, Karunanayake EH, Tennekoon KH, Allen M, Amarasinghe I, Angunawala P, et al. Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals. BMC Cancer. 2008; 8: 214.
29. Huyton T. Bates P.A. Zhang X. Sternberg M.J.E. Freemont P.S. The BRCA1 C-terminal domain: Structure and function Mutation Research - DNA Repair 2000 460 3 4 319-332 DOI 10.1016/S0921-8777(00)00034-3, PII S0921877700000343 29. Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS. The BRCA1 C-terminal domain: structure and function. Mutat Res. 2000; 460: 319-332. (Pubitemid 30628598)
30. Konstantopoulou I, Kroupis C, Ladopoulou A, Pantazidis A, Boumba D, Lianidou E, et al. BRCA1 mutation analysis in breast/ovarian cancer families from Greece. Hum Mutat. 2000; 16: 272-273.
31. Dunning A.M. Chiano M. Smith N.R. Dearden J. Gore M. Oakes S. Wilson C. Stratton M. Peto J. Easton D. Clayton D. Ponder B.A.J. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population Human Molecular Genetics 1997 6 2 285-289 DOI 10.1093/hmg/6.2.285 31. Dunning AM, Chiano M, Smith NR, Dearden J, Gore M, Oakes S, et al. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet. 1997; 6: 285-289. (Pubitemid 27078085)